ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$8.08
+4.60%
Mkt Cap $8.46B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (6 analysts)
$13.00
Range $12.00 – $15.00
Implied Upside
+61.0%
Consensus $13.00 vs current $8.08
NASDAQ·Healthcare·Biotechnology
$8.08
+4.60%
Mkt Cap $8.46B
Buy
9
Hold
0
Sell
0
Price Target (6 analysts)
$13.00
Range $12.00 – $15.00
+61.0%
Consensus $13.00 vs current $8.08